Home Recalls D-0488-2015
Class III · Low risk Terminated Initiated Mar 26, 2015 (11 years ago)
Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg…
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell
What was recalled
Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90
Recalling firm Actavis Laboratories, FL, Inc.
NDC code 62037-0600-90
Origin FL, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0488-2015
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class III · Low risk Ongoing Jun 3, 2026
Reason Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.
Class III · Low risk Ongoing May 4, 2026
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Ongoing Aug 18, 2025
Reason Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a…
Class II · Moderate risk Ongoing Aug 18, 2025
Reason Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a…
Class II · Moderate risk Ongoing Aug 18, 2025
Reason Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a…